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Abstract
 
Humoral immunity is maintained by long-lived plasma cells, constitutively secreting antibodies,
and nonsecreting resting memory B cells that are rapidly reactivated upon antigen encounter.
The activation requirements for resting memory B cells, particularly the role of T helper cells,
are unclear. To analyze the activation of memory B cells, mice were immunized with human
cytomegalovirus, a complex human herpesvirus, and tick-born encephalitis virus, and a simple
flavivirus. B cell populations devoid of Ig-secreting plasma cells were adoptively transferred
into T and B cell–deficient RAG-1
 
 
 
/
 
 
 
 mice. Antigenic stimulation 4–6 d after transfer of B
cells resulted in rapid IgG production. The response was long lasting and strictly antigen specific,
excluding polyclonal B cell activation. CD4
 
 
 
 T cells were not involved since (a) further depletion
of CD4
 
 
 
 T cells in the recipient mice did not alter the antibody response and (b) recipient
mice contained no detectable CD4
 
 
 
 T cells 90 d posttransfer. Memory B cells could not be
activated by a soluble viral protein without T cell help. Transfer of memory B cells into immuno-
competent animals indicated that presence of helper T cells did not enhance the memory B cell
response. Therefore, our results indicate that activation of virus-specific memory B cells to secrete
IgG is independent of cognate or bystander T cell help.
Key words: antigen-speciﬁc immunity • immunological memory • B lymphocyte memory • 
cytomegalovirus • adoptive transfer
 
Introduction
 
During a primary humoral immune response, interaction
between different cell types of the adaptive and innate
immune system is essential. In peripheral lymphoid organs,
APCs such as DCs and macrophages make contact with
antigen-specific T cells, resulting in T cell activation. B cells
that have encountered their antigen in the blood, the lymph
nodes, or on follicular DCs (FDCs) present antigen on
MHC class II molecules and migrate to the borders of the T
cell–rich areas of the lymphoid organs where cognate T–B
cell interaction occurs (1, 2). This interaction can result
either in differentiation of activated B cells into low affinity
IgM-secreting plasma cells or into memory B cell precursors
(3). These precursors are recruited into the germinal center
(GC) reactions. They form GCs where proliferation, somatic
mutation of the Ig genes, and antigenic selection by FDCs
takes place (4). The B cells differentiate into high affinity
IgG-, IgA-, or IgE-secreting plasma cells or they enter into
the memory B cell pool, carrying high affinity immunoglob-
ulin as surface receptors (4). A second encounter with the
same antigen leads to a much quicker activation of memory
B cells, resulting in the appearance of high affinity IgG-
secreting plasma cells within a few days (3).
The requirements for the memory B cell activation upon
this second antigen encounter and the involvement of T
cell help are not clear. A second round of T–B cell interaction
seemed to be essential for the activation of memory B cells
into IgG-secreting plasma cells in experimental protocols
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involving either immunization with soluble proteins and
hapten-carrier conjugates or viral infection of mice (5, 6).
Here, we analyzed the memory B cell activation in re-
sponse to two different enveloped viruses using adoptive
transfer of highly purified B cells from immunized donors
into recombinase-activating gene (RAG)-1
 
 
 
/
 
 
 
 mice. We
show that memory B cells can be activated by viral particles
to produce specific IgG with virus-neutralizing capacity in
the absence of helper T cells.
 
Materials and Methods
 
Mice.
 
8–12-wk-old C57BL/6 mice were obtained from
Charles River Laboratories. C57BL/6-RAG-1
 
 
 
/
 
 
 
 mice were
obtained from Irmgard Förster. C57BL/6-TCR
 
 
 
/
 
 
 
 
 
/
 
 
 
 mice
were obtained from The Jackson Laboratory. C57BL/6-TNF
 
 
 
/
 
 
 
,
C57BL/6-TNF/LT
 
 
 
 
 
/
 
 
 
 mice (7) and C57BL/6 Ly5.1 mice were
a gift from H. Körner (Nikolaus Fiebiger Center). All mice were
maintained free of specific pathogens in isolated ventilated cages.
 
Antigens and Immunizations.
 
Human cytomegalovirus (HCMV)
strain AD169 was propagated in primary human foreskin fibro-
blasts grown in MEM supplemented with 5% FCS, glutamine (100
mg/L), and gentamycine (350 mg/L). Virions and dense bodies
(DBs; enveloped particles missing the viral core) were isolated via
glycerol-tartrate gradient centrifugation as described (8).
Tick-born encephalitis virus (TBEV) particles and HCMV
glycoprotein B (gB) were gifts from Chiron Behring and Aventis
Pasteur, respectively. Both preparations corresponded to the anti-
gen used for vaccination in humans. C57BL/6 mice were immu-
nized twice with 20 
 
 
 
g HCMV-DBs, 2 
 
 
 
g TBEV particles, or
10 
 
 
 
g soluble gB in aluminum hydroxide i.p. at intervals of 4 wk
and with 10 
 
 
 
g HCMV-DBs, 2 
 
 
 
g TBEV, and 10 
 
 
 
g gB, re-
spectively, in PBS i.v., again after 4 wk. B cells for adoptive
transfer were isolated at least 6 wk after the last immunization.
 
Flow Cytometry and Adoptive Transfer of B Lymphocytes.
 
Single
cell suspensions of spleens from immunized mice were stained
with PE-conjugated anti-CD19 and FITC-conjugated anti-CD8
and anti-CD4 antibodies (all antibodies were obtained from BD
Biosciences). CD19
 
 
 
 cells were isolated by two rounds of cell
sorting using a MoFlo
 
®
 
 cell sorter (Cytomation) and analyzed for
purity by flow cytometry using a FACSCalibur
 
®
 
 (Becton Dickin-
son). For negative selection of B lymphocytes, single cell suspen-
sions of spleens from HCMV-DB–immunized mice were stained
with FITC-conjugated antibodies against CD4, CD8, TCR
 
 
 
,
TCR 
 
 
 
/
 
 
 
, NK1.1, CD11b, CD11c, and c-kit and propidium io-
dine. Positive cells were removed by two rounds of cell sorting.
In general, a purity 
 
 
 
99.8% was achieved by either procedure.
5 
 
 
 
 10
 
6
 
 purified CD19
 
 
 
 B cells were adoptively transferred
into the tail vein of C57BL/6–RAG-1
 
 
 
/
 
 
 
 mice. For adoptive
cotransfer of primed helper T cells, 5 
 
 
 
 10
 
6
 
 purified CD4
 
 
 
 T
cells from spleens and lymph nodes of C57BL/6 mice previously
immunized with HCMV-DBs were negatively selected after
staining with antibodies against CD19, CD8, NK1.1, CD11b,
and CD11c.
 
Antigen Injection and In Vivo Depletion.
 
On day 6 posttransfer
or at later time points, RAG-1
 
 
 
/
 
 
 
 mice were challenged with 10
and 2 
 
 
 
g of HCMV-DBs, TBEV, or gB i.v., respectively. For
the in vivo depletion of potentially contaminating CD4
 
 
 
 T cells
after adoptive transfer, mice were injected twice (2 d before and
on the day of challenge) with 500 
 
 
 
g each of purified GK1.5 an-
tibody (a gift from T. Brocker, Institute for Immunology, Mu-
nich, Germany). The same regimen was used for depletion of
CD4
 
 
 
 cells before transfer of memory B cells into immunocom-
petent hosts.
 
Detection of Specific Antibodies.
 
Sera from mice were analyzed
by ELISA for virus-specific IgG. Sera were diluted 1:100 and
compared with a dilution series of a hyperimmune serum from
Balb/c mice, which was included on each individual ELISA
plate. 2 
 
 
 
g/ml HCMV virions and 1 
 
 
 
g/ml TBEV particles, re-
spectively, were coated to ELISA plates. Relative intensity (RI)
corresponds to percentage of OD reached by a 1:400 dilution of
the hyperimmune serum.
The IgG subclass composition of sera was analyzed by ELISA
using subclass-specific, biotinylated antibodies (Southern Biotech-
nology Associates) and horseradish peroxidase–coupled Strept-
avidin (Amersham Biosciences). For the detection of specific anti-
bodies on Western blots, lysates of HCMV virions (2 
 
 
 
g/lane)
were separated by SDS-PAGE, and Western blotting was per-
formed by standard procedures using horseradish peroxidase–con-
jugated mouse IgG–specific antibodies (Southern Biotechnology
Associates).
 
Virus Neutralization Assay.
 
Virus neutralization assays were
performed as described (9).
 
Immunofluorescence Microscopy.
 
Tissue blocks from spleens were
embedded in optimal cutting temperature compound (Diatec) and
stored at 
 
 
 
80
 
 
 
C. Tissue sections (10 
 
 
 
m) were thawed onto gela-
tin-coated glass slides, air dried, fixed in acetone (for 10–15 min at
 
 
 
20
 
 
 
C), and rehydrated with PBS and 0.01% Tween 20 (Sigma-
Aldrich). Nonspecific binding sites were blocked for 30 min at
room temperature (RT) with PBS containing 0.1% BSA and 10%
FCS. Each incubation step lasted 30 min at RT alternating with
five washing steps in PBS/Tween (0.01%, 10 min, RT). Sections
were incubated with goat anti–mouse IgG-Cy3 (Jackson Labora-
tories). After an additional blocking step with mouse serum, slides
were incubated with FITC-conjugated anti-B220 (BD Bio-
sciences) or alternatively with FITC-conjugated peanut agglutinin
(Vector Laboratories) and biotinylated anti-CD45.2 (clone 104;
BD Biosciences) followed by streptavidin-conjugated Cy5 (Amer-
sham Biosciences). Sections were analyzed using an immunofluo-
rescence microscope (Carl Zeiss MicroImaging, Inc.) equipped
with high sensitivity gray scale digital camera (Openlab system;
Improvision). Separate color images were collected for each sec-
tion, analyzed, and merged afterwards. Final image processing was
performed using Corel Photo-Paint software.
 
Online Supplemental Material.
 
Fig. S1 (available at http://
www.jem.org/cgi/content/full/jem.20030091/DC1) shows the
purity of B cell populations after two rounds of cell sorting. Sin-
gle cell suspensions of spleens taken from C57BL/6 mice immu-
nized with HCMV-DBs were stained with PE-conjugated anti-
CD19 and FITC-conjugated anti-CD8 and anti-CD4 antibodies.
CD19
 
 
 
 cells were isolated by two rounds of cell sorting and ana-
lyzed for purity by FACS
 
®
 
.
 
Results
 
Memory B Cells Can Be Activated by Antigen after Adoptive
Transfer into Mice Lacking T Lymphocytes.
 
We chose to in-
vestigate the requirements for memory B cell activation us-
ing RAG-1
 
 
 
/
 
 
 
 mice, which are deficient of T and B cells,
as a host for adoptive transfer of memory B cells from mice
immunized with HCMV. The virus particle is composed
of 
 
 
 
30 structural proteins, including at least eight envelope
glycoproteins. As the prototypic 
 
 
 
-herpesvirus, it shows
strict species specificity, and therefore viral replication is re- 
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stricted to cells of human origin (10). To generate memory
B cells, C57BL/6 mice were immunized with HCMV-
DBs using standard procedures. HCMV-DBs represent
noninfectious enveloped particles that mainly consist of vi-
ral tegument proteins contained in a complete viral enve-
lope (11). Mice immunized with HCMV-DBs mount a
humoral and cellular immune response including CD4
 
 
 
and CD8
 
 
 
 T cells (12).
4 wk after the last immunization, blood was taken and
serum was analyzed for HCMV-specific IgG and neutraliz-
ing antibodies (a schematic outline of the experimental
protocol is provided in Fig. 1 A). Sera from all immunized
mice exhibited high titers of virus-specific IgG, as deter-
mined by ELISA, and considerable virus-neutralizing ac-
tivity (range 1:1,000–1:3,200; a representative analysis is
shown in Fig. 1 D). At different time points (42–200 d) af-
ter the last immunization, CD19-positive small resting B
cells were isolated from the spleen by two rounds of cell
sorting. In general, a purity of 
 
 
 
99.8% was achieved by
this procedure (Fig. S1, available at http://www.jem.org/
cgi/content/full/jem.20030091/DC1). Individual RAG-1
 
 
 
/
 
 
 
mice were infused with 5 
 
 
 
 10
 
6
 
 purified B cells, and 6 d
later the animals were either injected with 10 
 
 
 
g HCMV-
DBs i.v. or left untreated. Sera were analyzed for HCMV-
specific IgG between days 10 and 80 after transfer of B
cells. 10 d after antigen stimulation, HCMV-specific IgG
was clearly detectable (Fig. 1 B). The titers remained ele-
vated during the observation period of 80 d. In the adop-
tively transferred RAG-1
 
 
 
/
 
 
 
 mice, HCMV-specific IgG ti-
ters were 2–3 log2 dilutions lower than in immunized
animals, which was expected since only a fraction of the B
cells normally present in mice were used for the transfer. In
fact, transferring higher numbers of CD19
 
 
 
 B cells to re-
cipient mice resulted in elevated antibody titers (not de-
picted). In contrast, sera from RAG-1
 
 
 
/
 
 
 
 mice that had
been infused with B cells from naive donors and challenged
with HCMV-DBs remained negative for HCMV-specific
IgG during the entire observation period (Fig. 1 B). The
Figure 1. IgG reactivity and biological activity of recipient and donor sera.
(A) Summary of the experimental protocol for immunization, adoptive transfer,
and challenge with antigen. C57BL/6 mice were immunized twice with HCMV-
dense bodies. 200 d later, sorted B cells from the spleen were adoptively transferred
into RAG-1 /  recipients. On day 6 posttransfer, recipients were challenged with
10  g HCMV-DBs i.v., and sera were analyzed on the days indicated. (B) Sera
from recipients of B cells from immunized ( ) and naive (X) donors were ana-
lyzed by ELISA for HCMV-specific IgG. (C) Sera taken at day 40 postchallenge
were analyzed in immunoblots and compared with sera of donor mice. (D) Neu-
tralization activity of sera from RAG-1 /  mice adoptively transferred with
immune ( ) or naive (X) B cells and of sera from donor mice ( ) was analyzed in
vitro. (E) IgG subclass composition of donor sera ( ) (dilution 1:1,000) and recipient
sera ( ) (dilution, 1:200) analyzed by ELISA using subclass-specific antibodies.
Values correspond to the dilution above detection threshold. 
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use of CD19, which is not present on plasma cells, as the
target for B cell isolation and the absence of HCMV-spe-
cific IgG in RAG-1
 
 
 
/
 
 
 
 mice on day 6 after transfer of im-
mune B cells argued against the presence of IgG-producing
plasma cells in the transplant (Fig. 1 B). The lack of plasma
cells in the transplant was further corroborated by the fact
that RAG-1
 
 
 
/
 
 
 
 mice, which had received B cells from im-
mune donors but were not challenged with HCMV-DBs
for up to 90 d remained negative for HCMV-specific IgG
(see Fig. 6 A and not depicted).
The specificity of the antibody response was analyzed by
Western blot. A range of individual HCMV structural pro-
teins was recognized by antibodies from the recipient
RAG-1
 
 
 
/
 
 
 
 mice, which included those known to induce
an IgG response during natural infection of humans (Fig. 1
C). Most of the antibody specificities present in donor sera
were also detected in the recipient sera. No additional anti-
body specificities were generated in the recipient mice. Oc-
casionally the entire spectrum of donor specificities was not
recovered in the recipients, most likely as a result of the low
numbers of memory B cells that were transferred to the re-
cipient animals. However, antibodies directed against the
immunodominant envelope glycoprotein of HCMV, gp58,
which represents the transmembrane subunit of gB (13)
were detectable in all recipient sera. The antiviral activity of
immunoglobulins produced in RAG-1
 
 
 
/
 
 
 
 recipient mice
was tested in in vitro neutralization assays using infectious
HCMV as the target. Sera reached 50% neutralization titers
in dilutions between 1:60 and 1:200 (Fig. 1 D). Again, neu-
tralization titers of immunized C57BL/6 mice exceeded
those of recipient RAG-1
 
 
 
/
 
 
 
 mice by 2–3 log2 dilutions.
To further characterize the antibody response, the IgG
subclass composition of HCMV-specific antibodies was de-
termined. The distribution of IgG subclasses was similar be-
tween sera from donor and recipient mice with IgG1,
IgG2a, and IgG2b being the dominant subclasses, whereas
IgG3 was found in lower concentrations (Fig. 1 E). To ex-
clude a potential activating effect of the anti-CD19 anti-
body used during cell sorting, we also applied a negative
purification procedure by removing all non–B cells from
the spleen cell suspension. This procedure resulted in simi-
lar purity of the B cells and in identical IgG titers upon an-
tigen stimulation after transfer (unpublished data).
In RAG-1
 
 
 
/
 
 
 
 mice, a homeostatic expansion of a frac-
tion of B cells has been observed, which show an activated
phenotype (14). To exclude potential influences of the
complete lack of competition in the RAG-1
 
 
 
/
 
 
 
 system, we
used additional experimental settings. In a first set of ex-
periments, we used TCR
 
 
 
/
 
 
 
 
 
/
 
 
 
 mice devoid of any T
lymphocytes (15) as recipients for adoptively transferred
memory B cells from HCMV-DB–immunized C57BL/6
animals. These mice reacted equally well to antigenic stim-
ulation with HCMV-DBs as RAG-1
 
 /  recipients (Fig. 2).
In a second set of experiments, immunocompetent
C57BL/6 mice were treated with the monoclonal antibody
GK1.5 to eliminate endogenous CD4  T cells. These mice
were then used as hosts for memory B cells from HCMV-
DB–immunized donors. Recipient mice were stimulated
with antigen on day 1 after transfer. Whereas GK1.5 anti-
body treatment completely prevented an IgG response
against HCMV-DBs, it allowed production of IgG in ani-
mals that had received memory B cells (Fig. 2). Thus, the T
cell–independent memory B cell response that we observe
in RAG /  recipients is not a consequence of B cell ex-
pansion and homeostatic differentiation.
These results indicated that, after adoptive transfer into
mice devoid of T or T and B cells, highly purified B cells
from HCMV-DB–immunized C57BL/6 mice can be acti-
vated to produce specific IgG by antigenic stimulation.
Moreover, the lack of antibody production in mice receiv-
ing B cells from naive donors demonstrated that the pri-
mary antibody response against HCMV-DBs in mice is T
cell dependent.
Antibody Responses in Recipient Mice Are Generated in the
Absence of T Cells. Although the purity of our B cell
preparations argued against a participation of CD4  T cells
in the observed memory response, we further investigated a
potential involvement of small numbers of CD4  T cells in
this process. First, potentially contaminating CD4  T cells
were depleted in recipient RAG-1 /  mice after transfer
and before challenge. To this end, recipient mice were
treated with depleting CD4-specific antibody GK1.5. The
antibody concentration used was sufficient for a complete
abrogation of a primary antibody response to HCMV-DBs
in C57BL/6 mice (Fig. 2). When HCMV-DB–specific
IgG was measured between days 10 and 60 postchallenge,
no difference in antibody titers was observed between ani-
mals that had received GK1.5 and the control mice (Fig. 3
A). Second, spleens and blood of recipient mice were ana-
lyzed for the presence of CD4  T helper cells 90 d after
transfer. This time period is expected to be sufficient for
homeostatic expansion of potentially contaminating T cells
to detectable numbers (16). Neither the spleen nor the
Figure 2. IgG memory response in different host mice lacking func-
tional CD4  cells. 5   106 sorted B cells from hyperimmunized C57BL/6
mice were transferred as described in Fig. 1, and mice were challenged
with antigen 1 d after adoptive transfer of cells. The IgG antibody response
in different recipient mice was measured 7 d after challenge with 2  g
HCMV-DBs i.v. Controls received no memory B cell preparations. The
bars represent the mean of RI values; dots are individual values.Hebeis et al. 597
Figure 3. T cell depletion and T cell numbers in recipient mice.
(A) RAG-1 /  mice adoptively transferred with immune B cells
were injected with 500  g GK1.5 antibody 2 d before and on the
day of stimulation with 10  g HCMV-DBs. Blood was taken on
the days indicated, and sera were analyzed for HCMV-specific IgG
( ) compared with sera of untreated recipients ( ). (B) Spleens and
blood were taken from RAG-1 /  mice, RAG-1 /  mice 90 d
post adoptive transfer and from donor mice. Single cell suspensions
were stained with FITC- or PE-conjugated antibodies and analyzed
by FACScan. The specificities of the staining antibodies are indi-
cated at the axes.
blood of recipient RAG-1 /  mice harbored cells, which
were CD4 /TCR , indicating that the transferred B cell
population contained no or negligible numbers of CD4 
and CD8  or  / -TCR  T cells (Fig. 3 B).
Finally, we wanted to analyze a potential enhancing ef-
fect of virus-specific memory T cells on virus-specific
memory B cell responses by an adoptive cotransfer of
CD4  helper T cells into RAG-1 /  mice. However, a
rapid and dramatic inflammatory bowel disease developing
after the transfer of sorted CD4  cells into syngeneic
C57BL/6 RAG-1 /  mice prevented the analysis of the
influence of CD4  cells in the adoptive transfer experi-Activation of Virus-specific Memory B Cells 598
ments involving RAG-1 /  mice. For this reason, we de-
cided to adoptively transfer B cells from HCMV-DB–
immunized C57BL/6 mice into naive C57BL/6 mice with
or without CD4  T cells from the spleen and lymph node
of HCMV-DB–immunized mice as a source of primed T
cell help. As expected, the challenge of recipient and con-
trol mice with HCMV-DBs yielded faster IgG antibody re-
sponses with higher titer in recipients of sorted B cells con-
taining virus-specific memory B cells when compared with
naive control mice. Naive C57BL/6 mice responded to a
single i.v. immunization with HCMV-DBs since the mice
were not irradiated (Fig. 4). Importantly, the transfer of
CD4  cells from HCMV-DB–immunized C57BL/6 mice
together with sorted B cells did not enhance the virus-spe-
cific antibody response in the recipient mice (Fig. 4).
Virus-specific Memory B Cells Are Not Participating in Ger-
minal Center Reactions after Challenge with Virus. The lack
of enhancement of the memory IgG response in the pres-
ence of primed T cell help suggested that virus-specific
memory B cells are not participating in GC reactions upon
challenge with virus. Therefore, we assessed the formation
of GCs in naive C57BL/6-Ly5.1 mice after adoptive trans-
fer of memory B cell preparations together with primed
CD4  cells, both from C57BL/6-Ly5.2 mice and after
challenge with HCMV-DBs. GC reactions in the spleen
were detectable at day 8–10 after challenge, with 9–14 GCs
per section, whereas naive mice did not contain detectable
GCs (not depicted). Donor-derived cells did not participate
in any of more than 50 GCs analyzed (Fig. 5, B and C). In-
stead, clusters of donor-derived cells that were IgGhigh and
had partially down-regulated CD45 appeared as early as 4 d
after challenge outside B cell follicles and the T cell zone at
the border of the white pulp to the red pulp (Fig. 5, A and
B) at or close to the marginal zone.
The Memory B Cell Response Is Antigen Specific. It re-
mained a possibility that HCMV-DBs have the capacity for
B cell receptor–independent activation of B cells or a frac-
tion thereof. Since the antigen-specific memory compart-
ment contains an increased frequency of specific B cells, this
activation could result in the secretion of detectable amounts
of HCMV-specific IgG in recipients of memory B cells.
To investigate this possibility, we included TBEV parti-
cles as a second viral antigen in the experimental protocol.
Figure 4. Antibody responses
after adoptive transfer of memory
B and memory T cells. C57BL/6
mice received 5   106 B cells
from C57BL/6 mice immunized
with HCMV-DBs ( ), 5   106
immune B cells together with
5    106 CD4  T cells from
C57BL/6 mice previously immu-
nized with HCMV-DBs ( ) or
no cells ( ). On day 6 posttrans-
fer, the mice were challenged
with 2  g HCMV-DBs i.v. Blood was taken at the days indicated, and
sera were analyzed by ELISA for HCMV-specific IgG. The values represent
the mean values (  SD) of four recipient mice, and one of two similar
experiments is shown.
Figure 5. Localization of the IgG response in the presence of T cell
help. Memory B cell preparations (5   106 CD19  cells) together
with primed CD4  cells (2.5   106 cells), both from C57BL/6-Ly5.2
mice, were transferred into naive C57BL/6-Ly5.1 mice and challenged
with HCMV-DBs 1 d after adoptive transfer. (A) 4 d after challenge,
clusters of donor-derived (CD45.2 in blue), IgGhigh (red) cells were
observed outside the follicles (thick arrows). B220 is stained in green.
(B) 10 d after challenge, clusters of donor-derived (CD45.2, blue), IgGhigh
(red) cells are still persistent (thick arrows); in addition IgG  GCs
could be observed inside the follicles (thin arrows). The cells partici-
pating in the GC reaction are CD45.2 negative. (C) A GC from day
10 after challenge is stained with peanut agglutinin (green). Donor
CD45.2 cells are blue; IgG-positive cells are red. Magnification: (A and
B) 50 ; (C) 200 .Hebeis et al. 599
TBEV is a member of the Flaviviridae. The envelope con-
sists of a lipid bilayer containing the two viral proteins M
and E. The E protein is the target for the neutralizing hu-
moral immune response (17). C57BL/6 mice were immu-
nized with both antigens simultaneously, and the develop-
ment of a humoral immune response against both viruses
was confirmed at least 4 wk after the last immunization
(not depicted). CD19  B cells were isolated and adoptively
transferred to RAG-1 /  mice as described above. Be-
tween 4 and 7 d posttransfer, mice were challenged with
either HCMV-DBs or TBEV i.v. On day 10 after chal-
lenge, only recipients injected with TBEV developed
TBEV-specific IgG titers, whereas serum from mice that
had received HCMV-DBs had no detectable TBEV-spe-
cific antibody titer and vice versa (Fig. 6 A). The specific
antibody titers remained elevated for the observation pe-
riod of 40 d. In immunoblots, sera from TBEV recipient
animals reacted exclusively with the E protein, which cor-
responded to the specificity found in sera of the B cell do-
nor mice (Fig. 6 B). To determine if B cells retained the
capacity to be activated with either antigen, recipient mice
were stimulated with the reciprocal antigen 90 d after
adoptive cell transfer. IgG titers similar to those produced
after stimulation at early time points posttransfer developed
within 1 wk (Fig. 6 A). We conclude from these experi-
ments that neither HCMV-DBs nor TBEV induce a B cell
receptor–independent activation of memory B cells in the
recipient mice. The responding memory B cells seem to
have a life span of at least 90 d.
To investigate whether the particulate structure of the
antigen is of importance for the activation of memory B
cells, we adoptively transferred cells from C57BL/6 mice
immunized with a recombinant monomeric form of the vi-
ral envelope protein gB. This protein has been used for
immunization in humans (18) but is also highly immuno-
genic in mice (19). When recipient mice were challenged
with gB, no antibody titer developed (Fig. 6 C). Like-
wise, gB was not capable of stimulating memory B cells
from HCMV-DB–immunized animals. In contrast, stimula-
tion of memory B cells from gB-immunized mice with
HCMV-DBs resulted in IgG production similar to mice
that had been primed with HCMV-DBs.
Together, these data show that two unrelated enveloped
viruses are capable of activating memory B cells in the ab-
sence of T helper cells. The physical nature of the challeng-
ing antigen seems to be of importance for the differentia-
tion of memory B cells into IgG-secreting cells.
An Organized Lymphoid Tissue Is Required for T Cell–inde-
pendent Differentiation of Virus-specific Memory B Cells. In a
series of experiments, we noted that transferred memory B
cells were unresponsive to challenge with HCMV-DBs
when the antigen was applied within minutes after the in-
jection of memory B cell preparations, a protocol that is
widely used for the assessment of memory B cell function.
This effect was observed in RAG-1 /  recipients, T cell / 
mice, and anti-CD4–treated recipients. In contrast, when
virus particles were given 24 h after adoptive transfer, a full
response was measurable in T cell /  mice (unpublished
Figure 6. Specificity of the IgG response
of adoptively transferred memory B cells.
(A) C57BL/6 mice were immunized with
HCMV-DBs and TBEV particles, and
CD19  cells were isolated and transferred to
RAG-1 /  mice according to the legend
for Fig. 1 A. On day 4 posttransfer, recipients
were challenged with 10  g HCMV-DBs
( ) or 2  g TBEV particles ( ). Blood was
taken at the days indicated, and sera were
analyzed by ELISA for TBEV- (left) and
HCMV-specific (right) IgG reactivity, respec-
tively. On day 90 posttransfer, recipients
were immunized again (arrows), this time
using the reciprocal antigen, and IgG titers
were determined. (B) Sera taken at day 40
poststimulation (dilution, 1:250) and sera of
donor mice (dilution, 1:40,00) were analyzed
by Western blot for IgG specificities against
lysates of TBEV particles. (C) C57BL/6 mice
were immunized with either a recombinant
monomeric form of the HCMV viral en-
velope protein gB or HCMV-DBs, and
CD19  cells were isolated and transferred to
RAG-1 /  mice according to Fig. 1 A. On
day 7 posttransfer, recipients were challenged
with either 2  g HCMV-DBs or 10  g
recombinant  gB. The bars represent the
mean of RI values; dots are individual values.
The experiment was repeated twice with
similar results.Activation of Virus-specific Memory B Cells 600
data). These findings suggested that memory B cells needed
to migrate to a specific lymphoid compartment in order to
become fully responsive to antigenic stimulation in a T cell–
independent way. To test this, we used TNF /  and TNF/
LT  /  mice as recipients in which the organization of the
lymphoid architecture is severely altered (20). Wild-type,
TNF / , and TNF/LT  /  C57BL/6 mice were treated
with anti-CD4–specific antibody, and memory B cell prep-
arations were adoptively transferred. An IgG memory re-
sponse was clearly detectable in anti-CD4–treated wild-type
mice, whereas only a minute IgG response was detected in
TNF /  recipients (Fig. 7). In TNF/LT  /  recipients, the
IgG memory response was completely absent, likewise in
anti-CD4–treated C57BL/6 mice that had not received
memory cells (Fig. 7). These results indicate that homing of
memory B cells to secondary lymphoid tissue is required for
the T cell–independent memory B cell response.
Discussion
Our results show that virus-specific memory B cell re-
sponses do not require T cell help. After transfer of B cells
from immunized mice, RAG-1 /  mice and mice that are
devoid of T cells but contain a normal B cell compartment
developed a specific IgG titre. The responding cell popula-
tion in the recipient mice consisted of antigen-specific,
resting B memory cells, since (a) only small, CD19  B cells
were sorted from the donor mice, (b) antigen-specific IgG
was undetectable after adoptive transfer in the recipient
mice even after a prolonged period of time in the absence
of antigen, and (c) the response after challenge with antigen
exhibited all the characteristics of a memory response with
regard to both kinetics and Ig isotype. Furthermore and in
accordance with previous findings (21, 22), the transferred
memory B cells appear to be long-lived in the RAG-1 / 
mice in the absence of T cells, since specific responses with
similar titers could be induced even 3 mo after transfer (Fig.
6 A). Interestingly, the presence of primed T cell help in
immunocompetent C57/BL6 mice did not enhance anti-
body production after antigenic stimulation of adoptively
transferred memory B cells, indicating that in virus-specific
humoral memory responses cognate or bystander T cell
help plays a minor role.
Our experiments with the viral glycoprotein gB as a sol-
uble monomer clearly indicate that, as expected, memory
B cell responses against monomeric protein antigens cannot
be induced in the absence of T cell help. In this experi-
mental system that provides a model for a physiological
secondary response against exotoxins, T cell help appar-
ently is a strict requirement. The presentation of the anti-
gen during challenge seems to dictate whether a T-inde-
pendent memory response can be induced, but not the
presentation of the antigen during generation of B memory
cells, as memory B cells generated by immunization with
gB in adjuvant could be activated by virus particles.
Some virus infections can elicit an IgG response in the
absence of T cell help. Requirements seem to be a repeti-
tive and highly organized antigenic structure that occurs in
structurally simple nonenveloped viruses, such as vesicular
stomatitis virus or polyomavirus (23). However, when in-
activated viruses or viral proteins are used for immuniza-
tion the switch to IgG production is strictly dependent on
T cell help (24–26). In accordance with these findings, we
observed T cell dependence for a primary B cell response
against HCMV particles in CD4  T cell–depleted mice
and undetectable IgM responses after immunization of
RAG-1 /  mice that had been adoptively transferred with
naive B cells (unpublished data). These results rule out a T
cell–independent primary antibody response against our
antigens. Activation of virus-specific memory B cells has
also been reported to be strictly dependent on specific T
cell help (6). This is in contrast to our study where trans-
ferred memory B cells were effectively stimulated to dif-
ferentiate into antibody-secreting cells in the absence of T
cells, indicating that neither specific nor bystander T cell
help is required for the activation of memory B cells. One
possible explanation for the difference could be the exper-
imental protocol (6). In the adoptive transfer experiments
reported by Ochsenbein et al. (6), antigen was given 20
min after transfer of memory B cells into anti-CD4–
treated recipients. In our experiments in RAG-1 /  mice
or anti-CD4–treated immunocompetent recipients chal-
lenged with virus, shortly after transfer of purified B cells
an IgG antivirus response was also undetectable. However,
challenge with antigen 24 h after transfer of memory cells
induced a response. Interestingly, challenge with antigen
shortly after transfer of memory cells is widely and tra-
ditionally used in experiments assessing the function of
memory B cells (5, 27).
Our findings strongly suggest that virus-specific memory
B cells must home to specific sites within the lymphoid sys-
Figure 7. IgG memory response in recipient mice with altered lym-
phoid architecture. 5   106 sorted B cells from a pool of hyperimmu-
nized C57BL/6 mice were transferred as described in the legend for Fig.
1, and mice were challenged with antigen 1 d after adoptive transfer of
cells. Control C57BL/6 mice were treated with GK1.5 antibody but
received no memory B cell preparations. The IgG antibody response in
different recipient mice treated with GK1.5 antibody was measured 7 d
after challenge with 2  g HCMV-DBs i.v. The bars represent the mean
of RI values; dots are individual values. The experiment was repeated,
and similar results were obtained.Hebeis et al. 601
tem to become antigen responsive in a T cell–independent
way. The observation that a T cell–independent differenti-
ation of virus-specific memory B cells could not be in-
duced in TNF/Lt  /  or TNF /  recipient mice supports
this view and confirms earlier data that lymphoid architec-
ture, which depends on the expression of LT  for its
development and maintenance, is needed to support a
memory Ig response after antigenic challenge (28). Experi-
mentally provided T cell help might overcome the require-
ment for homing to specific sites in secondary lymphoid
organs (6). The bone marrow has been shown recently to
be a location for T cell priming for blood-born antigens
(29), and it has been suggested that memory B cells might
interact with primed T helper cells in the bone marrow of
splenectomized ALY/ALY mice that lack lymph nodes and
Peyer’s patches (6).
What are the costimulatory requirements for a virus-
specific memory B cell in the absence of T cell help? One
possibility is that FDCs that are crucial for the generation
of memory cells (30) might also be essential for the differ-
entiation after antigen challenge. Since B lymphocytes are
sufficient to induce a FDC network upon transfer in SCID
mice (31), this possibility cannot be ruled out. The failure
to induce a T cell–independent memory B cell response
against virus particles after transfer of cells into TNF- and
TNF/LT -deficient recipients (Fig. 7) might imply a fun-
damental role of FDC networks for memory B cell activa-
tion, as FDC networks are absent in these mice (7, 32, 33).
An alternative explanation for the absence of a mem-
ory response in TNF- and TNF/LT -deficient recipients
might be the lack of a detectable marginal sinus in the
spleen of these mice (7). For rats and humans, it has been
shown that memory B cells can reside in the marginal zone
of the spleen (34, 35). The localization of clusters of cells
expressing high levels of IgG after challenge with virus
(Fig. 5) is compatible with an activation of these cells in
the marginal zone. Virus-specific memory cells could po-
tentially receive important costimuli while located in the
marginal zone, similar to IgM  marginal zone B cells reac-
tive to blood-born bacteria (36). The exact localization
and the nature of costimuli for memory B cells to become
activated in a T cell–independent way need to be fur-
ther elucidated. Other possible costimulatory signals for
memory B cells could originate from the innate immune
system, particularly complement components (37), type I
interferons (38), or pattern recognition receptors on B
cells (39).
Understanding the mechanism(s) of memory B cell acti-
vation will not only provide fundamental information
about this important cell type of the humoral immune sys-
tem but could also be of clinical importance. HCMV rep-
resents an important pathogen in bone marrow or stem cell
transplant recipients in the early phases after transplantation,
at times when T cell–dependent virus-specific humoral re-
sponses are not possible. Expanding the pool of memory B
cells or vaccination strategies to activate residual virus
memory B cells might be of benefit for the course of the
infection in these patients.
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